CSMYF(CSMYF)
CSMYF
No analyst ratings available
No analyst price targets available for CSMYF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.17T | $1.24T | $1.36T | $1.45T |
| Low | $1.13T | $1.20T | $1.32T | $1.41T |
| High | $1.19T | $1.27T | $1.39T | $1.49T |
| EBITDA Avg | $73.75B | $78.75B | $86.11B | $92.08B |
| Low | $71.42B | $76.27B | $83.39B | $89.17B |
| High | $75.28B | $80.40B | $87.91B | $94.00B |
| EBIT Avg | $49.84B | $53.22B | $58.20B | $62.23B |
| Low | $48.27B | $51.54B | $56.36B | $60.26B |
| High | $50.88B | $54.33B | $59.41B | $63.53B |
| Net Income Avg | $32.62B | $34.37B | $40.23B | $42.68B |
| Low | $31.28B | $32.96B | $38.58B | $40.93B |
| High | $33.50B | $35.30B | $41.32B | $43.84B |
| EPS Avg | $411.54 | $433.63 | $507.61 | $538.49 |
| Low | $394.64 | $415.82 | $486.77 | $516.37 |
| High | $422.70 | $445.39 | $521.38 | $553.09 |
| Analysts (Rev / EPS) | 10 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $293.74B | $282.29B | $289.81B | $302.45B |
| Low | $291.10B | $279.75B | $287.20B | $299.73B |
| High | $297.25B | $285.66B | $293.27B | $306.06B |
| EBITDA Avg | $18.59B | $17.87B | $18.34B | $19.14B |
| Low | $18.42B | $17.71B | $18.18B | $18.97B |
| High | $18.81B | $18.08B | $18.56B | $19.37B |
| EBIT Avg | $12.57B | $12.08B | $12.40B | $12.94B |
| Low | $12.45B | $11.97B | $12.29B | $12.82B |
| High | $12.71B | $12.22B | $12.54B | $13.09B |
| Net Income Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EPS Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 1 / — | 2 / — | 2 / — |